MedPath

Piramal Critical Care BV

🇳🇱Netherlands
Ownership
Subsidiary
Employees
-
Market Cap
-
Website
http://www.piramal.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

26

CIMA_AEMPS:23
EMA:3

Drug Approvals

Sugammadex Piramal

Authorization Status
Authorised
Approval Date
Jun 23, 2023
EMA

Yargesa

Authorization Status
Authorised
Approval Date
Mar 22, 2017
EMA

Yargesa

Authorization Status
Authorised
Approval Date
Mar 22, 2017
EMA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.